Pharmaceutical Technology - May 2022

Pharmaceutical Technology- May 2022

Issue link:

Contents of this Issue


Page 4 of 63

4 Pharmaceutical Technology TRENDS IN MANUFACTURING 2022 eBOOK P h a r mTe c h . c o m Solid Dosage A lternative dosage forms are helping the pharmaceutical industry tackle some of the challenges associated with efficacy and patient adherence. For example, oral films that help administer treatments to pediatric and geri- atric patients, and wearable injectors that enable the self-adminis- tering of high-volume treatments. Amid these innovations, it's easy to overlook the humble tablets and capsules that have been used for generations and continue to be the most popular course of treatment around the world. The global capsule market is expected to grow at a compound annual growth rate of 8.1% from 2021 to 2030 (1). This amounts to approximately 700 billion units every year around the world, according to ACG data. But capsules are more than the familiar favorite. Recent developments are taking oral solid dosage (OSD) solutions to new heights. Now more than ever, innovation is fueled by the need to differentiate and deliver sustainable, advanced products in the crowded pharma- ceutical market. Pharmaceutical manufacturers must also navigate evolving delivery formats, the economy of scale, complex regulatory landscapes, increasingly stressed supply chains, and digitalization, all while maintaining the highest quality standards. Therefore, it's crucial to take steps to meet these growing challenges using the latest advanced manufacturing technologies. The continued rise of OSD forms OSD forms are a popular choice among pharmaceutical manu- facturers and continue to play an important role in developing Manufacturing OSD Forms: Key Trends Shaping the Industry Laxman Shetty, Jnanadeva Bhat, and Anita Solanki The latest manufacturing technologies are essential for helping pharmaceutical formulators meet up-and-coming trends in OSD treatments. Laxman Shetty is the vice president, operations; Jnanadeva Bhat is the vice president, formulation R&D (pharma and nutra); and Anita Solanki is the lead for whitepapers and publications, formulation R&D (pharma and nutra), all for ACG. PROXIMA STUDIO - STOCK.ADOBE.COM

Articles in this issue

Links on this page

Archives of this issue

view archives of Pharmaceutical Technology - May 2022 - Pharmaceutical Technology- May 2022